C19orf64 Activators would represent a class of compounds specifically engineered to interact with and upregulate the biological activity of the protein encoded by the human C19orf64 gene. This gene, denoted as C19orf64, is located on chromosome 19 and encodes a protein whose function is not extensively documented within the scientific literature. Proteins encoded by open reading frames (ORFs) like C19orf64 are often of interest due to their potential involvement in complex cellular processes. To facilitate the development of activators for C19orf64, comprehensive structural and functional analyses would be imperative. Techniques such as X-ray crystallography or cryo-electron microscopy could be employed to clarify the three-dimensional structure of the C19orf64 protein, thereby revealing potential interaction sites for small molecules. Additionally, understanding the biological role and interaction partners of C19orf64 would be essential to determine the appropriate mechanism by which an activator could enhance its activity.
Once potential interaction domains on the C19orf64 protein have been mapped, the design and synthesis of specific activator molecules would commence. This phase would likely involve a combination of computational chemistry and empirical screening methodologies. Molecular docking simulations would be used to predict how small molecules might interact with the protein at a molecular level, identifying candidates that could stabilize the protein in an active conformation or enhance its intrinsic activity. Following in silico screening, promising compounds would be synthesized and subjected to a battery of biochemical assays to empirically test their ability to activate the C19orf64 protein. These assays could include binding studies to confirm interaction with the protein, as well as functional assays to measure any increase in the protein's activity in the presence of the compounds. Through iterative rounds of compound synthesis and testing, the pharmacological profile of the activators would be optimized, yielding a set of refined C19orf64 Activators. These molecules would serve as essential research tools, aiding in the elucidation of the physiological and cellular role of the C19orf64 protein and providing insight into its function within the context of the cellular environment.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is an HDAC inhibitor, potentially relaxing chromatin structure and increasing transcription of various genes, possibly including GIPC3. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
This compound is a DNA methyltransferase inhibitor, potentially leading to the demethylation and activation of gene promoters, including possibly GIPC3. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), which can lead to changes in gene expression, potentially affecting GIPC3. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that can increase cAMP and activate transcription factors, possibly influencing GIPC3 expression. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin raises intracellular calcium levels, which can activate various signaling pathways and potentially induce GIPC3 expression. | ||||||
Dimethyl Sulfoxide (DMSO) | 67-68-5 | sc-202581 sc-202581A sc-202581B | 100 ml 500 ml 4 L | $30.00 $115.00 $900.00 | 136 | |
DMSO can influence gene expression as a solvent for many biological studies, potentially altering the expression of a wide array of genes, including GIPC3. | ||||||
Vitamin A | 68-26-8 | sc-280187 sc-280187A | 1 g 10 g | $377.00 $2602.00 | ||
Retinol, a form of vitamin A, is involved in gene regulation and could potentially influence the expression of genes including GIPC3. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone is a glucocorticoid that can affect gene transcription through the glucocorticoid receptor, potentially modifying GIPC3 expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor that can result in chromatin remodeling and affect gene expression, possibly including GIPC3. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
Bisphenol A can interact with estrogen receptors and influence gene expression patterns, potentially affecting GIPC3 expression. | ||||||